Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
On July 15th, Hemai Medical (03309.HK) spent HKD 134,300 to repurchase 140,000 shares.
15/07/2026
The Zhitong Finance APP reported that Hima Medical (03309.HK) announced the repurchase of 140,000 shares for HK$134,000 on July 15, 2026.
Latest
2 m ago
Kailai Pharmaceutical-B (02105.HK) spent 288,100 Hong Kong dollars on July 15 to repurchase 39,000 shares.
3 m ago
Kangzhe Pharmaceuticals (00867): The independently developed innovative drug complement factor B inhibitor CMS-D017 has obtained the approval notice for clinical trials of age-related macular degeneration indications.
3 m ago
Ruihui raised CLOUDFLARE's target price from $260 to $310.
3 m ago
TaiMei Medical Technology (025776.HK) spent 323,200 Hong Kong dollars on July 15 to repurchase 52,400 shares.
3 m ago
Cloud Alpha (02670.HK) repurchased 8,450 shares for HKD 1.4091 million on July 15th.
See all latest